Two of the UK’s publicly funded nanotechtechnology promotion bodies have joined forces to speed the development of applications in regenerative medicine, diagnostics, imaging and drug discovery.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.